BCI on the Road
Professor Frances Balkwill Invited Speaker at AACR Annual Meeting 2013
6-10 April 2013, Washington, DC
Professor Frances Balkwill will be speaking at the American Association for Cancer Research (AACR) Annual Meeting 2013 on 6 April, with "The Central Role of the Microenvironment in Initiation and Progression of Tumors and Response to Chemotherapy" as her session title. This educational session will cover highlights of some of the promising work in the rapidly expanding field of the tumor microenvironment.
Professor Balkwill will also chair and speak at a major symposium on Inflammation and Cancer on 10 April. The theme of this session is inflammatory pathways in malignant progression and therapeutic targets that are emerging from this research. The session will present new data on the role of oncogenic mutations in stimulating inflammatory tumor microenvironments and the potential of targeting chemokine receptors or tumor-promoting macrophages in cancer.
Founded in 1907, the AACR is the oldest and largest scientific organisation in the world dedicated to the study of cancer.
Please click here to find out more about the AACR and view the meeting program.
The Rally for Medical Research will also take place during the AACR Annual Meeting on the 8th April 2013, in support for sustained investment in medical research. Attendees are encouraged to join in the rally.
|Photos from the AACR and Rally.|
BCI at the NCRI Conference, 4-7 November 2012
BCI will be exhibiting at the 8th NCRI Cancer Conference, Liverpool, UK
4-7 November 2012
Come and see us on stand no. 4
Come and meet our Professor
BCI researchers will be presenting a variety of sessions, presentations and posters, please see below for details.
Monday 5 November
Plenary lecture (Hall 1A, 09.00-09.40)
Targeting myeloma cells and their microenvironment
Kenneth C. Anderson, Dana-Farber Cancer Institute
Sponsored by Barts Cancer Institute
Parallel Sessions - Ovarian cancer: Turning knowledge into treatment (Room 3B, 15.50 - 17.20)
- Ovarian cancer: Turning knowledge into treatment
Poster Session A
- RH10 - Investigating the Functional Effects of Oncogenic FGFR2 Mutations in Endometrial Cancer
Best Poster Prize Winner (2nd Place)
Abbie Fearon, Pedro Cutillas, Richard Grose
- A217 - Investigating the role of nuclear FGF2 and FGFR1 in pancreatic cancer
Stacey Coleman, Richard Grose, Hemant Kocher
- A45 - Renal cell cancer (RCC) heterogeneity and differential protein expression pre- and post-sunitinib therapy
Grant D Stewart, Fiach C O'Mahony, Lel Eory, Alexander Lubbock, Jyoti Nanda, Alexander Laird, Maire O'Donnell, Antony CP Riddick, S Alan McNeill, Michael Aitchison, Daniel Berney, John Peters, Andrea Rockall, Anju Sahdev, Axel Bex, Dana Faratian, Simon Chowdhury, David J Harrison, Ian Overton, Thomas Powles
Tuesday 6 November
Poster Session B
- B165 - Identification of protein interacting partners for the breast cancer associated transcription factor TFAP2C; implications for cell cycle progression
Fabrizio Miranda, Ping-Pui Wong, Roberto Giambruno, Keiryn L Bennett, Giulio Superti-Furga, Helen C Hurst, Angelo G Scibetta
- B185 - FGFR1 cleavage and nuclear translocation regulates breast cancer cell behaviour
Athina Myrto Chioni, Richard Grose
- B162 - Investigating the functional significance of FGFR2 SNP status in breast cancer
Luisa Robbez-Masson, Csaba Bodor, Louise Jones, Helen Hurst, Ian Hart, Richard Grose
- B22 - E1B19K-deleted adenoviruses and DNA-damaging chemo-drugs synergize to kill cancer cells through mechanisms involving induction of mitotic and DNA aberrations
Constantia Pantelidou, Gioia Cherubini, Nick R. Lemoine, Gunnel Hallden
- B172 Protein kinase activity of p110alpha PI 3-kinase: a search for physiological substrates by mass spectrometry
Michael Walsh, Pedro Cutillas, Bart Vanhaesebroeck
- B176 - Development of a cell-based assay to study the impact of the class III phosphoinositide 3-kinase on cancer cell biology
Michalina Gruszka, Benoit Bilanges, Bart Vanhaesebroeck
Wednesday 7 November
Parallel Sessions - Tumour angiogenesis (Room 11, 10.00 - 11.00)
- Introduction: Tumour angiogenesis
Meet the Professor
|Meet the Professor: Kairbaan Hodivala-Dilke|
|Date||Tuesday 6 November|
|Time||17:30 - 19:00|
Room 8, First floor, BT Convention Centre
NCRI 2012 - Day 1 & 2
Dr Peter Szlosarek talks about the ADAM trial in the 2012 IMig Meeting, Boston, US
Dr Peter Szlosarek will be speaking at the 2012 IMig (International Mesothelioma Interest Group) Meeting on Thursday 13 September 2012, (Session IVB).
His talk is entitled 'Arginine deprivation with pegylated arginine deiminase (ADI-PEG20) in patients with malignant pleural mesothelioma (MPM): preliminary results of a multicenter randomized phase II trial'.'The iMig is an independent international group of scientists and clinicians working to understand, cure and prevent Mesothelioma.'
- BCI at the 17th Congress of the European Hematology Association - Amsterdam
- Prof John Gribben is an invited speaker at ASCO Annual Meeting 2012
- Dr Pedro Cutillas attending the 60th American Society for Mass Spectrometry conference - Vancouver, Canada
- BCI at the Keystone Symposia - Dublin, Ireland May 2012
- Prof John Gribben speaks at the Aberdeen Immunology Group
- Dr Jude Fitzgibbon speaks at the joint ACC/CMGS Genetics Spring Conference 2012
- BCI at the American Association for Cancer Research Annual Meeting 2012, Chicago IL
- Dr Inas El-Najjar presenting at the EBMT 2012 - Geneva, Switzerland
- Prof Bart Vanhaesebroeck speaks at the 12th Hunter Meeting, NSW, Australia
- Prof Bart Vanhaesebroeck speaks at Biochemical Journal Symposium in San Diego, USA